List of Tables
Table 1. Global Drug Abuse Testing Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Drug Abuse Testing Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Drug Abuse Testing Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Drug Abuse Testing Products Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drug Abuse Testing Products Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Drug Abuse Testing Products Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Drug Abuse Testing Products Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Drug Abuse Testing Products by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Testing Products as of 2024)
Table 11. Global Drug Abuse Testing Products Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Drug Abuse Testing Products Companies Headquarters
Table 13. Global Drug Abuse Testing Products Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Drug Abuse Testing Products Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Drug Abuse Testing Products Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Drug Abuse Testing Products Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Drug Abuse Testing Products Revenue by Application (2026-2031) & (US$ Million)
Table 21. Drug Abuse Testing Products High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Drug Abuse Testing Products Growth Accelerators and Market Barriers
Table 25. North America Drug Abuse Testing Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Drug Abuse Testing Products Growth Accelerators and Market Barriers
Table 27. Europe Drug Abuse Testing Products Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Drug Abuse Testing Products Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Drug Abuse Testing Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Drug Abuse Testing Products Investment Opportunities and Key Challenges
Table 31. Central and South America Drug Abuse Testing Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Drug Abuse Testing Products Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Drug Abuse Testing Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Biomedical Diagnostics Corporation Information
Table 35. Biomedical Diagnostics Description and Major Businesses
Table 36. Biomedical Diagnostics Product Features and Attributes
Table 37. Biomedical Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Biomedical Diagnostics Revenue Proportion by Product in 2024
Table 39. Biomedical Diagnostics Revenue Proportion by Application in 2024
Table 40. Biomedical Diagnostics Revenue Proportion by Geographic Area in 2024
Table 41. Biomedical Diagnostics Drug Abuse Testing Products SWOT Analysis
Table 42. Biomedical Diagnostics Recent Developments
Table 43. BioMerieux Corporation Information
Table 44. BioMerieux Description and Major Businesses
Table 45. BioMerieux Product Features and Attributes
Table 46. BioMerieux Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. BioMerieux Revenue Proportion by Product in 2024
Table 48. BioMerieux Revenue Proportion by Application in 2024
Table 49. BioMerieux Revenue Proportion by Geographic Area in 2024
Table 50. BioMerieux Drug Abuse Testing Products SWOT Analysis
Table 51. BioMerieux Recent Developments
Table 52. Abbott Laboratories Corporation Information
Table 53. Abbott Laboratories Description and Major Businesses
Table 54. Abbott Laboratories Product Features and Attributes
Table 55. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Abbott Laboratories Revenue Proportion by Product in 2024
Table 57. Abbott Laboratories Revenue Proportion by Application in 2024
Table 58. Abbott Laboratories Revenue Proportion by Geographic Area in 2024
Table 59. Abbott Laboratories Drug Abuse Testing Products SWOT Analysis
Table 60. Abbott Laboratories Recent Developments
Table 61. Bio-Rad Corporation Information
Table 62. Bio-Rad Description and Major Businesses
Table 63. Bio-Rad Product Features and Attributes
Table 64. Bio-Rad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Bio-Rad Revenue Proportion by Product in 2024
Table 66. Bio-Rad Revenue Proportion by Application in 2024
Table 67. Bio-Rad Revenue Proportion by Geographic Area in 2024
Table 68. Bio-Rad Drug Abuse Testing Products SWOT Analysis
Table 69. Bio-Rad Recent Developments
Table 70. Dako Corporation Information
Table 71. Dako Description and Major Businesses
Table 72. Dako Product Features and Attributes
Table 73. Dako Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Dako Revenue Proportion by Product in 2024
Table 75. Dako Revenue Proportion by Application in 2024
Table 76. Dako Revenue Proportion by Geographic Area in 2024
Table 77. Dako Drug Abuse Testing Products SWOT Analysis
Table 78. Dako Recent Developments
Table 79. DiaSorin Corporation Information
Table 80. DiaSorin Description and Major Businesses
Table 81. DiaSorin Product Features and Attributes
Table 82. DiaSorin Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. DiaSorin Recent Developments
Table 84. Eiken Corporation Information
Table 85. Eiken Description and Major Businesses
Table 86. Eiken Product Features and Attributes
Table 87. Eiken Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Eiken Recent Developments
Table 89. Fujirebio Corporation Information
Table 90. Fujirebio Description and Major Businesses
Table 91. Fujirebio Product Features and Attributes
Table 92. Fujirebio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Fujirebio Recent Developments
Table 94. Beckman Coulter Corporation Information
Table 95. Beckman Coulter Description and Major Businesses
Table 96. Beckman Coulter Product Features and Attributes
Table 97. Beckman Coulter Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Beckman Coulter Recent Developments
Table 99. Siemens Corporation Information
Table 100. Siemens Description and Major Businesses
Table 101. Siemens Product Features and Attributes
Table 102. Siemens Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Siemens Recent Developments
Table 104. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Corporation Information
Table 105. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Description and Major Businesses
Table 106. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Product Features and Attributes
Table 107. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Recent Developments
Table 109. Laboratory Corporation Of America Holdings Corporation Information
Table 110. Laboratory Corporation Of America Holdings Description and Major Businesses
Table 111. Laboratory Corporation Of America Holdings Product Features and Attributes
Table 112. Laboratory Corporation Of America Holdings Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Laboratory Corporation Of America Holdings Recent Developments
Table 114. Danaher Corporation Corporation Information
Table 115. Danaher Corporation Description and Major Businesses
Table 116. Danaher Corporation Product Features and Attributes
Table 117. Danaher Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Danaher Corporation Recent Developments
Table 119. Express Diagnostics International Inc Corporation Information
Table 120. Express Diagnostics International Inc Description and Major Businesses
Table 121. Express Diagnostics International Inc Product Features and Attributes
Table 122. Express Diagnostics International Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Express Diagnostics International Inc Recent Developments
Table 124. Quest Diagnostics Incorporated Corporation Information
Table 125. Quest Diagnostics Incorporated Description and Major Businesses
Table 126. Quest Diagnostics Incorporated Product Features and Attributes
Table 127. Quest Diagnostics Incorporated Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Quest Diagnostics Incorporated Recent Developments
Table 129. Thermo Fisher Scientific Inc Corporation Information
Table 130. Thermo Fisher Scientific Inc Description and Major Businesses
Table 131. Thermo Fisher Scientific Inc Product Features and Attributes
Table 132. Thermo Fisher Scientific Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Thermo Fisher Scientific Inc Recent Developments
Table 134. Drgerwerk Ag & Co. Corporation Information
Table 135. Drgerwerk Ag & Co. Description and Major Businesses
Table 136. Drgerwerk Ag & Co. Product Features and Attributes
Table 137. Drgerwerk Ag & Co. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Drgerwerk Ag & Co. Recent Developments
Table 139. Kgaa Corporation Information
Table 140. Kgaa Description and Major Businesses
Table 141. Kgaa Product Features and Attributes
Table 142. Kgaa Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Kgaa Recent Developments
Table 144. Raw Materials Key Suppliers
Table 145. Distributors List
Table 146. Market Trends and Market Evolution
Table 147. Market Drivers and Opportunities
Table 148. Market Challenges, Risks, and Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Abuse Testing Products Product Picture
Figure 2. Global Drug Abuse Testing Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Analyzers Product Picture
Figure 4. Rapid Testing Devices Product Picture
Figure 5. Consumables Product Picture
Figure 6. Global Drug Abuse Testing Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Workplaces and Schools
Figure 8. Criminal Justice Systems and Law Enforcement Agencies
Figure 9. Hospitals
Figure 10. Others
Figure 11. Drug Abuse Testing Products Report Years Considered
Figure 12. Global Drug Abuse Testing Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 14. Global Drug Abuse Testing Products Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Drug Abuse Testing Products Revenue Market Share by Region (2020-2031)
Figure 16. Global Drug Abuse Testing Products Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Analyzers Revenue Market Share by Player in 2024
Figure 19. Rapid Testing Devices Revenue Market Share by Player in 2024
Figure 20. Consumables Revenue Market Share by Player in 2024
Figure 21. Global Drug Abuse Testing Products Revenue Market Share by Type (2020-2031)
Figure 22. Global Drug Abuse Testing Products Revenue Market Share by Application (2020-2031)
Figure 23. North America Drug Abuse Testing Products Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Drug Abuse Testing Products Revenue (US$ Million) in 2024
Figure 25. North America Drug Abuse Testing Products Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Drug Abuse Testing Products Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Drug Abuse Testing Products Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Drug Abuse Testing Products Revenue (US$ Million) in 2024
Figure 32. Europe Drug Abuse Testing Products Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Drug Abuse Testing Products Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 35. France Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Drug Abuse Testing Products Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Drug Abuse Testing Products Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Drug Abuse Testing Products Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Drug Abuse Testing Products Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 47. India Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Drug Abuse Testing Products Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Drug Abuse Testing Products Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Drug Abuse Testing Products Revenue (US$ Million) in 2024
Figure 55. Central and South America Drug Abuse Testing Products Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Drug Abuse Testing Products Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Drug Abuse Testing Products Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Drug Abuse Testing Products Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Drug Abuse Testing Products Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Drug Abuse Testing Products Revenue (US$ Million) in 2024
Figure 61. South America Drug Abuse Testing Products Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Drug Abuse Testing Products Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Drug Abuse Testing Products Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Drug Abuse Testing Products Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Drug Abuse Testing Products Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Drug Abuse Testing Products Revenue (2020-2025) & (US$ Million)
Figure 67. Drug Abuse Testing Products Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
